Cargando…
Evaluation of anifrolumab safety in systemic lupus erythematosus: A meta-analysis and systematic review
OBJECTIVES: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, and type I interferon plays an important role in its pathogenesis. Anifrolumab is a new strategy for the treatment of systemic lupus erythematosus. It could antagonize the activity of all type 1 interferons by binding wi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537685/ https://www.ncbi.nlm.nih.gov/pubmed/36211347 http://dx.doi.org/10.3389/fimmu.2022.996662 |